Billionaire Profile
Xiu Laigui
Global Rank
#3154

Image: Unsplash Contributor | Unsplash License | via Unsplash

Xiu Laigui

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$1.172B
Estimated based on Pharmaceuticals stock value as of April 21, 2026
0% (24h)
Age
71
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Xiu Laigui is a Chinese pharmaceutical billionaire, the founder, and current chairman of Xiuzheng Pharmaceutical Group, one of China's largest pharmaceutical companies. His wealth stems from his leadership and strategic vision in the pharmaceutical industry, specifically his pioneering efforts in modernizing and scaling Traditional Chinese Medicine (TCM) through Yiling Pharmaceutical, which gained international recognition during the COVID-19 pandemic. Xiu Laigui's career began as a police officer before transitioning into the pharmaceutical sector in 1995, acquiring a small, debt-ridden factory. His achievements include transforming Xiuzheng into a leading pharmaceutical enterprise and successfully executing an IPO. His net worth is estimated at $1.2 billion as of 2024. He maintains a professional and composed style, and is known for scientific validation of TCM.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life

Xiu Laigui was born in 1954 in Changchun City, Jilin Province, China. He holds a B.A. in Medicine from Jilin University. Before entering the pharmaceutical industry, Xiu served as an equipment technician in the Tonghua Traffic Police Detachment.

Rise to Success

In 1995, Xiu Laigui founded Xiuzheng Pharmaceutical Group by acquiring a debt-ridden, state-owned drug factory. Through strategic vision and hard work, he transformed the company into a leading pharmaceutical enterprise in China. He pioneered the modern, scalable TCM industrial model, successfully executing an IPO on the Shenzhen Stock Exchange (SZSE). His most popular product, Sidashu capsules, is a stomach pain medication. His company's product, Lianhua Qingwen, gained international attention during the COVID-19 pandemic.

Key Business Strategies

Xiu Laigui focused on the scientific validation of TCM. He built a nationwide marketing network. He invested heavily in building a first-class R&D base and the largest Chinese herbal medicine production base in the province, and building the most modern “biomedical science and technology park” in the country. Xiuzheng's key strategies included system innovation and the establishment of a modern enterprise system.

Philanthropy

Xiu Laigui's personal philanthropy supports various community and educational initiatives.

Career Milestones

1995

Founded Xiuzheng Pharmaceutical Group

Acquired a small, debt-ridden state-owned drug factory and built it into a major pharmaceutical company.

1992

Founded Yiling Pharmaceutical

Recognizing the demand for scientifically validated TCM products

Philanthropy & Social Impact

Medical research and education

Various medical research and educational initiatives

Undisclosed

Supports community and educational initiatives.

Business Philosophy & Leadership

Leadership Principles

Scientific validation of TCM

Emphasis on the scientific validation of traditional Chinese medicine to transform the perception and production of traditional remedies.

Controversies & Challenges

2012

Toxic Capsule Scandal

Xiuzheng Pharmaceutical Group was involved in a scandal involving capsules made from industrial gelatin, leading to product recalls and loss of consumer confidence.